Medicine and Dentistry
Iron
89%
Iron Deficiency
72%
Hypochromic Anemia
71%
Anemia
71%
Malignant Neoplasm
67%
Pediatrics
65%
Pediatric Cancer
62%
Quality of Life
62%
Symptomatic Treatment
46%
Randomized Controlled Trial
45%
Reticulocyte
44%
Thalassemia Major
41%
Childhood Cancer
41%
Iron Overload
36%
Pediatrics Patient
31%
Acute Lymphoblastic Leukemia
31%
Prevalence
30%
Cross Sectional Study
25%
Ferritin
24%
Pediatric Quality of Life Inventory
24%
Diseases
24%
Cancer
23%
Chronic Disease
20%
Prognostic Factor
20%
T Cell
20%
Chronic Kidney Disease
20%
Hepcidin
20%
Prematurity
20%
Ischemic Heart Disease
20%
Amino Terminal Sequence
20%
Socioeconomic Status
20%
Iron Supplement
20%
QTc Interval
20%
Hemodialysis
20%
QT Prolongation
20%
Chemotherapy-Induced Nausea and Vomiting
20%
Heart Hemosiderosis
20%
Brain Natriuretic Peptide
20%
Low Drug Dose
20%
End Stage Renal Disease
20%
Multiplex Ligation Dependent Probe Amplification
20%
Acute B-Cell Lymphoblastic Leukemia
20%
Adjuvant Therapy
20%
Family Functioning
20%
Nausea and Vomiting
20%
Zusanli
20%
Retching
17%
Treatment Group
16%
Iron Depletion
16%
Magnetic Resonance Imaging
15%
Keyphrases
Iron Deficiency
100%
Iron Deficiency Anemia
95%
Reticulocyte Hemoglobin Content
65%
Quality of Life
62%
Acute Lymphoblastic Leukemia
57%
Children with Cancer
56%
Iron Profile
46%
Randomized Controlled Trial
44%
Anemia in children
42%
β-Thalassemia (β-thal)
41%
Pediatric Cancer Patients
41%
Iron Status
36%
Induction Period
31%
Ferritin
29%
Anemia
28%
Pediatric Patients
25%
Chemotherapy
25%
Cardiac Iron Overload
25%
Anemia Prevalence
25%
Palliative Interventions
24%
Hypertension
24%
Home Visits
24%
Risk Factors
23%
Indonesia
23%
Childhood Acute Lymphoblastic Leukemia
23%
Childhood Cancer
23%
Palliative Care
22%
Developing Countries
22%
Malignancy
21%
Developing Country Perspective
20%
L-asparaginase
20%
Disease-related Malnutrition
20%
Anemia of Chronic Kidney Disease
20%
Corticosteroid Injection
20%
Renal Infiltration
20%
Premature Coronary Heart Disease
20%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
20%
Parental History
20%
Screening Scale
20%
Pediatric Palliative Care
20%
Chronic Kidney Disease in children
20%
High-dose Corticosteroids
20%
Intravenous Iron
20%
Coronary Artery Disease
20%
Pada
20%
Corrected QT Interval Prolongation
20%
Home-based
20%
Chemotherapy-induced Nausea
20%
Patients with Chronic Diseases
20%
Prognostic Factors
20%
Pharmacology, Toxicology and Pharmaceutical Science
Iron
98%
Anemia
69%
Iron Deficiency
53%
Iron Deficiency Anemia
47%
Thalassemia Major
41%
Acute Lymphoblastic Leukemia
41%
Iron Poisoning
36%
Malignant Neoplasm
30%
Prevalence
30%
Chronic Disease
27%
Chemotherapy
26%
Asparaginase
20%
Maintenance Dose
20%
QT Prolongation
20%
Hemodialysis
20%
Chronic Kidney Failure
20%
Chemotherapy Induced Nausea and Vomiting
20%
Heart Hemosiderosis
20%
Hepcidin
20%
Diseases
20%
End Stage Renal Disease
20%
Hyperglycemia
20%
Prematurity
20%
Midazolam
20%
Zusanli
20%
Childhood Cancer
20%
Ischemic Heart Disease
20%
Brain Natriuretic Peptide
20%
Ferritin
18%
Nausea and Vomiting
15%
Cross-Sectional Study
14%
Treatment Group
13%
Myocardial Disease
13%
Retching
13%
Dexamethasone
12%
Biological Marker
12%
Diastolic Dysfunction
10%
Prednisone
9%
Transferrin
9%
Side Effect
7%
Hyperlipidemia
6%
Clinical Trial
6%
Hemosiderosis
5%
Congestive Heart Failure
5%
Disease Marker
5%
Amino Terminal Pro Brain Natriuretic Peptide
5%
